BioNTech has been boosted a wave of enthusiasm over another company’s cancer drug, which has turned the biopharma industry ...
Pfizer and BioNTech’s Omicron KP.2-adapted COVID-19 vaccine has received a positive recommendation from the European ...
Updated COVID-19 vaccines are now widely available at many pharmacies, but for New Mexicans who lack insurance, the wait will be longer and supplies less certain. The New Mexico Department of Health ...
Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and ...
The latest strain of the COVID-19 virus, XEC, is circulating across the country. The new variant has been reported in at ...
Pfizer and BioNTech said on Friday that a committee from the European Medicine Agency recommended marketing authorization for its Omicron adapted vaccine to prevent Covid-19, meaning the vaccine is ...
It’s been over four years since the beginning of the COVID-19 pandemic. And since then, the virus has changed substantially.
The latest, highly contagious subvariants are driving infections, but new vaccines may help stem the tide of another wave — ...
Hong Kong will have another choice for a Covid-19 vaccine targeting the Omicron variant, with drug maker BioNTech offering to make its second-generation jabs available in the city as early as ...
Pfizer Inc. (NYSE: PFE, "Pfizer") and BioNTech SE (Nasdaq: BNTX, "BioNTech") today announced that the Committee for Medicinal Products for Human Use ...
Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and older Data demonstrate that the Omicron KP.2-adapted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback